by Christine Tatum | Jun 9, 2016 | Marijuana, Research
The marijuana states of Colorado, Oregon and Washington are not included in the 2015 state-level Centers for Disease Control’s Youth Risk Behavior Surveillance System (YRBSS) study released today. Those states either did not participate or did not have adequate...
by Chris Thurstone | Jun 1, 2016 | Marijuana, Research
The Journal of the American Academy of Child & Adolescent Psychiatry (JAACAP), recently published a study claiming a significant drop in marijuana-related problems among teenagers, such as addiction and having trouble at school. As with all review of scientific...
by Chris Thurstone | Mar 18, 2016 | Marijuana, Research
The news from London-based GW Pharmaceuticals is worth celebrating: Epidiolex — purified, pharmacy-grade and nonintoxicating cannabidiol extracted from the cannabis plant — has both Orphan Drug Designation and Fast Track Designation from the U.S. Food and...
by Christine Tatum | Dec 24, 2015 | Marijuana, Research
Research of cannabidiol, a non-intoxicating component of the cannabis plant, has been made easier because of new regulations released this week by the Drug Enforcement Administration. The federal agency has waived certain registration requirements for researchers...
by Christine Tatum | Dec 16, 2015 | Marijuana, Research
The national landscape of drug use among the nation’s middle-school and high-school students is showing both signs of promise and trouble ahead, according to The University of Michigan’s annual Monitoring the Future study, released today. A quick...
by Christine Tatum | Dec 10, 2015 | Marijuana, Research
This week’s annual meeting of the American Epilepsy Society has included the presentation and discussion of several papers about Epidiolex, a purified CBD oil produced by GW Pharmaceuticals. Epidiolex, which is now in clinical trials, is widely considered among...